lmmunoelectron microscopic studies in human neutrophils showed that FcRlll was present on the plasma membrane, in the Golgi complex, and in many small vesicles (120 to 180 nm). FcRlll was not found in specific or azurophilic granules as shown by immunogold double-labeling experiments, visualizing both FcRlll and either lactoferrin (a marker of specific granules) or myeloperoxidase (a marker for azurophilic granules). Because the occurrence of FcRlll in the Golgi complex suggested that biosynthesis of this receptor occurs in these cells, metabolic labeling experiments were HE PLASMA MEMBRANE of phagocytes bears vari-T ous receptors that recognize the Fc portion of immunoglobulin G (Fc,R). These receptors mediate the binding and endocytosis of soluble antibody-antigen complexes and IgGcoated particles. Among the Fc,R described, the 50-to 70-Kd murine Fc receptor for IgG1/2b (FcRII) has received the most attention. Its molecular structure has been characterized and it is known to be a member of the Ig gene ~uperfamily.'.~ Furthermore, the uptake of immune complexes through FcRII has been studied. Binding and endocytosis of polyvalent immune complexes by mouse macrophages lead to delivery of the ligand and FcRII to lysosomes in which both are degraded.' In the absence of bound ligand or when FcRII is tagged with a monovalent antireceptor antibody, the receptor is still internalized but is then rapidly returned to the plasma membrane instead of being delivered to the lys~somes.~~' This suggests that aggregation of FcRII is a prerequisite for delivery to lysosomes.
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Normal resting human neutrophils bear the 40-Kd FcRIl and the 50-to 80-Kd FcRIII (for a review of the literature on human leukocyte Fc,R, see reference 8). The structure of both receptors has recently been c h a r a c t e r i~e d .~~~. '~ Although the Fc receptor-mediated endocytosis of polyvalent ligands in human neutrophils has been described," little is known about the intracellular fate of the endocytosed FcRII and FcRIII. Indeed, the intracellular distribution of human Fc receptors, whether in the absence or presence of bound ligand, has not been established.
The present immunoelectron microscopic study was undertaken to visualize FcRIIl in human neutrophils in the absence of bound ligand. The work was restricted to FcRIII because this receptor has a much higher level of expression (100,000 to 200,000 per cell on the average) and can therefore be detected much more easily than FcRII (7,500 to 15,000 per cell on the average).'* FcRIII was found to occur along the plasma membrane, in small vesicles distributed throughout the cytoplasm, and in the Golgi complex. Because the presence of Fc receptors in the Golgi complex suggested biosynthesis of FcRII1, we performed metabolic labeling experiments that showed conclusively that de novo synthesis of FcRIII occurs in mature human neutrophils.
MATERIALS AND METHODS

Antibodies.
Monoclonal antibody (MoAb) CLB-FcR-granl, which is directed against FcRIII (formerly designated FcR,,), was described previou~ly'~; we term it anti-FcRIII. The polycional antibody against lactoferrin has been used in imm~nocytochemistry.'~ This antibody and the rabbit anti-mouse IgG were both purchased from Cappel Laboratories, West Chester, PA. The polyclonal antibody against myeloper~xidase'~ and MoAb W6/32 directed against HLA A, Bi6 were described previously.
Leukocyte isolation procedure f o r immunocytochemistry.
Leukocytes were obtained from heparinized blood of healthy individuals. Erythrocytes were removed by dextran sedimentation for 1 hour at room temperature. In some cell types, temperatures between 15OC and 2OoC selectively block certain steps in the endocytotic or exocytotic path~ay.".'~ To determine whether dextran sedimentation for 1 hour at rmm temperature would affect the intracellular localization of FcRIII, we omitted the removal of erythrocytes and fixed the fresh blood immediately in a graded formaldehyde series as described. This method proved acceptable, because most of the erythrocytes were lysed in 8% formaldehyde owing to the high osmolarity of this solution. Although the number of residual erythrocytes varied considerably and preservation of the ultrastructure was not consistent, localization of FcRIII in these cells was comparable with that in cells from which erythrocytes had been removed with dextran. On these grounds, we concluded that dextran sedimentation does not influence the intracellular localization of FcRIII, and in all experiments use was made of cells freed of erythrocytes before fixation.
To evaluate various fixation procedures with respect to preservation of antigenicity, we used a radioactive antibody-binding assay. One million leukocytes from which residual erythrocytes had been removed by Effect of fixation on FcRIJI and ultrastructure.
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lysis with an isotonic 0.89% NH,CI buffer for 5 minutes at 4OC were exposed to each of the fixatives for I hour at room temperature. The fixatives included 1% formaldehyde, 8% formaldehyde, and 1% formaldehyde combined with 0.1% acrolein or 0.1% glutaraldehyde. Fixed cells were incubated with anti-FcRIII for 1 hour at 4OC, washed, incubated with '251-labeled anti-mouse IgG for 16 hours at 4OC, and washed again. Bound radioactivity was measured with a y-counter. Unfixed cells exposed to the same antibodies served as controls, and values for IZ51 binding were corrected for nonspecific second-antibody binding by subtracting the amount of bound radioactivity when anti-FcRIII had been omitted. Fixatives containing only formaldehyde proved to be the most effective in preserving the antigenicity of FcRIII: more than 85% of anti-FcRIII binding was retained after fixation. Cells exposed to fixatives containing glutaraldehyde or acrolein showed less than 15% antibody binding. The most detailed and reproducible ultrastructure in cryosections was obtained when cells were fixed in a graded (1% to 8%) formaldehyde series in NaHCO, buffer at pH 7.4 (freshly prepared from paraformaldehyde) for 2 hours at room temperature."
Fixed cells were pelleted in 10% gelatin in phosphate-buffered saline (PBS), after which the pellet was postfixed overnight in 1% formaldehyde in 0.1 mol/L phosphate buffer (pH 7.4). On the next day, small gelatin blocks containing cells were infused with 2.3 mol/L sucrose in PBS for 25 minutes, mounted on a specimen holder, and frozen in liquid nitrogen. The pellets were not kept in the postfixation solution for more than 1 week, because after that interval the antigenicity of the Fc receptor was markedly reduced. Cryosectioning was performed according to the method of Tokuyasu.*' The sections were preincubated on drops of incubation buffer containing 0.1% bovine serum albumin (BSA), 0.1% "60 Bloom" gelatin,22 and 0.15% glycine in PBS, and labeled with the MoAb against FcRIII or with polyclonal antibodies directed against myeloperoxidase or lactoferrin. All antibodies were diluted in incubation buffer, and labeling was performed at room temperature for 60 minutes. The antibodies were visualized with protein A conjugated to 5-or 10-nm colloidal gold particle^.'^ Because of the low affinity of protein A for some classes of murine IgG, a second antibody (rabbit anti-mouse) and protein A conjugated to gold were used to visualize anti-FcRIII.
Controls included omission of the primary antibody incubation step and, for anti-FcRIII, incubation with a nonspecific murine IgG of the same class as the latter (IgG2a). Immunogold double-labeling of FcRIII and myeloperoxidase or lactoferrin was performed essentially as described by Geuze et incubation with the MoAb was always the first step in the labeling procedure. Lastly, the cryosections were embedded in a mixture of methylcellulose (methocel 25 mPa.s) and uranylacetate." All sections were examined with a Philips EM 410 or EM 300 at 80 kV.
The density of the gold particles over subcellular compartments after immunogold labeling of FcRIII was evaluated quantitatively. In this analysis, we used 10 micrographs of sections in which FcRIII and lactoferrin were labeled with, 10-and 5-nm gold and 10 micrographs of sections in which FcRIII (IO-nm gold) and myeloperoxidase (5-nm gold) were labeled, respectively. The surface area of cytoplasmic vesicles, the Golgi complex, lactoferrin-positive granules, myeloperoxidase-positive granules, and the nucleus was evaluated with a transparent paper with lattice placed over a micrograph, according to Weibel et aLZ6 The labeling density was expressed as the number of gold particles per square micron.
Purification and metabolic labeling of human neutrophils. Neutrophils were obtained from a leukocyte-rich buffy coat of 500 mL freshly citrated blood. The buffy coat was diluted three times with citrated PBS, and leukocytes were separated over isotonic Percoll of 1.076 g/mL (1,000 g for 20 minutes at ZOOC).
Immunocytochemistry.
Quantitative analysis of the immunogold labeling.
Erythrocytes in the granulocyte-rich pellet fraction were lysed with isotonic 0.89% NH,C1 at 4OC. Cell debris, which can cause clumping of the cells, was removed by passing the cell suspension through a cotton-wool column (3 x 0.5 cm). The cell preparation then showed 95% neutrophils; the remaining 5% was accounted for predominantly by eosinophils, as judged by light microscopy.
Neutrophils were cultured in a 2-cmZ flat-bottom well (24-well flat-bottom culture dishes, Nunc, Roskilde, Denmark). Each well contained twenty million neutrophils in 1 mL methionine-free RPMI to which 0.35 pmol/L methionine (18.5 Mbeq, Amersham International, Bucks, England) was added. After 18 hours of culture, the neutrophils were washed in PBS.
The labeled cells were incubated with the protease inhibitor diisopropyl-fluorophosphate (DIT, 2 mmol/L in PBS) for 10 minutes at 4OC. These cells were lysed at 4OC for 1 hour in 0.01 mol/L Tris HCL buffer containing 1% NP40, 0.15 mol/L NaCI, 5 mmol/L Na, EDTA, 250 mmol/L L-methionine, and two protease inhibitors (ie, 1 mmol/L phenylmethyl sulfanylfluoride [PMSF] and 0.02 mg/mL soy-bean trypsin inhibitor). Immunoprecipitation from the lysates of these labeled cells was performed with the MoAb against FcRIII and with MoAb W6/32 directed against HLA A, B, as described previou~ly.~~ Sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) was performed on discontinuous vertical slab gels according to a modification of the Laemmli procedure. 28 The isolated antigens were resuspended in 40 p L SDS sample buffer containing 0.15 mol/L Tris-HC1, 6% SDS, and 15% 8-mercaptoethanol and heated for 5 minutes at 100°C before electrophoresis was performed on 10% (wt/vol) slab gels. For autoradiography, gels were incubated in autoradiography enhancer (En3Hance, WEW Research Products, Dupont Chemical, Boston, MA), dried, and exposed to Kodak Y-Omat RP x-ray films.
Immunoprecipitation.
Electrophoresis and autoradiography.
RESULTS
In ultrathin cryosections of formaldehyde-fixed neutrophils, the cellular organelles were wellpreserved (Fig 1) . The wide range of the size and electron density of the granules dispersed throughout the cytoplasm made it difficult to discriminate between the various types of granule solely on the basis of morphologic
In the juxtanuclear area between the lobes of the nucleus, a small Golgi complex and one or two centrioles were generally found (Figs 2 and 3) . A few mitochondria were present, but elements of rough endoplasmic reticulum were not observed.
Immunogold labeling of FcRIII in cryosections showed that the receptor was present on the plasma membrane (Figs 1 and 4) . Intracellularly, FcRIII was present in small vesicles found throughout the cytoplasm (Fig 1) . In addition, FcRIII occurred in the cisternae of the Golgi complex, and the small vesicles were often seen close to the Golgi complex in the juxtanuclear area (Figs 2 and 3) . The vesicles are spherical or elongate, approximately 180 nm long and 120 nm wide, and have a low electron density. We assume that the receptors ate present inside the vesicles and are membrane associated, because the gold particles used to visualize the receptor often occurred along the inner surface of the limiting membrane of the vesicles.
Occasionally, neutrophil granulocytes contained structures that could be characterized as phagosomes according to morphologic criteria described by Silverstein et al. 32 We assume that these phagosomes had arisen during the isolation procedure or were formed while the cell was still in the Ultrastructure.
Localization of FcRZZZ. circulation. Fc receptors were also present along the limiting membrane of these phagosomes (Fig 4 inset) . Some cells had a multivesicular endosome containing FcRIII (not shown).
To determine whether FcRIII was present in either specific or azurophilic granules, we performed immunogold double-labeling experiments. FcRIII was labeled with IO-nm gold particles; for lactoferrin (a marker for specific granules) and myeloperoxidase (a marker for azurophilic granules) 5-nm gold particles were used.I4 Results showed that FcRIII was present in cytoplasmic vesicles and not in granules labeled with 5-nm gold (Figs 5 and 6) .
To determine the distribution of gold particles over the subcellular compartments after immunogold labeling of FcRIII. we
Quantitative analysis of immunogold labeling.
counted gold particles in micrographs of IO representative cells. Twenty-seven percent of the label was found along the plasma membrane and the remaining 73% was located over intracellular compartments.
In all experiments in which immunogold labeling of FcRIII was performed, some gold particles were found over the nuclear lobes and granules as well. We therefore determined the density of the gold particles over the various intracellular compartments after immunogold labeling of FcRIII. For this analysis, we used micrographs taken from sections in which FcRIII and myeloperoxidase or lactoferrin had been labeled. The results ( phils. We therefore labeled neutrophils with "S-methionine for 18 hours and performed an immunoprecipitation with anti-FcRIII from the lysate. We found a diffuse band between 50 and 70 Kd (Fig 7, lane 2) that corresponded with the band found when FcRIII is precipitated from a lysate of surface iodinated cells is shown in Fig 7, lane 2.'3.'4 In addition, a distinct band of 37-Kd occurred (Fig 7, lane 2) . Because this band was not found in all experiments, it has not been characterized and may represent an artifact. This 37-Kd band is not found when FcRIII is precipitated from a lysate of surface iodinated As a control, we immunoprecipitated the HLA class I molecules from the lysate using the antibody W6/32.I6 In lane 3, we found the 44-Kd HLA class I molecules and the noncovalently-associated 12-Kd @,-microglobulin. No other bands were found in this lane.
DISCUSSION
Immunogold labeling has proved an excellent technique for visualization of receptors and their ligands before and after internalization by the In the absence of bound ligand, FcRIII was found on the plasma membrane. Intracellularly, FcRIII occurred in a large population of the small vesicles ( 1 20 to 180 nm) dispersed throughout the cytoplasm. Many of these vesicles were present in the juxtanuclear area near the Golgi complex. Immunogold double-labeling experiments and quantitative analysis of the results showed that no Fc receptors were present in either the azurophilic (labeled with antimyeloperoxidase) or specific (labeled with antilactoferrin) granules.
The origin of the vesicles containing FcRIII could not be established in this study because electron microscopic immunocytochemistry can give only a static picture of a dynamic process. Therefore, whether these vesicles are part of an endocytotic or an exocytotic pathway is uncertain. Furthermore, the vesicles may constitute an internal pool of Fc receptors that can be mobilized and rapidly transported to the plasma membrane after stimulation (ie, in analogy with internal pools for the complement receptors CRI and CR3)." However, the observation of FcRIII throughout the entire Golgi complex indicates involvement in an exocytotic pathway.
Transport of newly synthesized FcRIII to the plasma membrane. Studies of the exocytotic pathway of newly synthesized membrane proteins" have shown that membrane proteins are generally produced in the endoplasmic reticulum, pass through the Golgi cisternae, and then are transported to the plasma membrane in small vesicles.
Electron microscopic studies of formation of granules in specific developmental stages of the neutrophil granulocyte have shown that granule production ceases after the myelocyte stage; therefore, the Golgi apparatus has been considered inactive in mature neutrophils." Although mature neutrophils are unable to produce granules, they synthesize other proteins such as fibronectin" and the common acute lymphoblastic leukemia antigen. 40 The localization of FcRIII throughout the Golgi complex suggested that biosynthesis of this receptor can occur in mature human neutrophils, which led us to undertake metabolic labeling experiments.
Immunoprecipitation with anti-FcRIII from NP40 lysates of mature neutrophils labeled with "S-methionine showed a diffuse band between 50 and 70 Kd which corresponds with the band found after precipitation of FcRIII from a lysate of surface iodinated neutrophil^."^^^ In addition, we found that immunoprecipitation of P2-microglobulin and HLA class I from the lysate was possible. These results clearly demonstrate that mature circulating neutrophils are capable of biosynthesis of FcRIII, &-microglobulin, and HLA class I. The Occurrence of biosynthesis of FcRIII in these cells suggests that at least some of the vesicles containing the receptor derive from the Golgi complex and are involved in transport of newly synthesized FcRIII to the plasma membrane.
De novo synthesis of FcRIII does not necessarily mean that all vesicles containing FcRIII are involved in transport of newly synthesized FcRIII from the Golgi complex to the plasma membrane. Indeed, distinct internal pools for the complement receptors CRl and CR3 have been described in human neutrophils, and in all likelihood the specific granules contain CR3.4' The complement receptors in these pools can be mobilized and rapidly transported to the plasma membrane after stimulation of the Alternative pathways. Evidence indicating the existence of an internal pool of FcRIII has been less convincing. In several studies, stimulation of neutrophils did not lead to increased expression of FcRIII along the plasma me~nbrane.".~~.~' However, we recently showed that FcRIII is a phosphatidyl inositol-linked receptor which is released from the plasma membrane on activati0n.4~ Thus, triggered transport of FcRIII from an intracellular pool to the plasma membrane does not necessarily lead to increased expression of the receptor on the plasma membrane, because release of FcRIII Occurs under this condition as well. Therefore, some of the vesicles containing FcRIII may represent an internal pool of Fc receptors.
According to another hypothesis, the vesicles containing FcRIII may originate from the plasma membrane by endocytosis. Membrane recycling has been described in macrophages, and unoccupied Fc receptors become internalized along with the other plasma membrane polypeptides and are recycled back to the plasma membrane.6s7 Membrane recycling has not been studied in human neutrophils, and whether Fc receptors participate in this process is not known. Studies to detect and characterize endocytotic pathways of FcRIII in the absence of bound ligand are now in progress in our laboratory.
